Breast Cancer Business, International Growth Drive up Genomic Health's Q2 Revenues 17 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market on Wednesday that its second-quarter revenues climbed 17 percent year over year on the strength of its US breast cancer business and growth internationally.

For the three months ended June 30, the Redwood City, Calif., company said revenues reached $50.8 million, up from $43.4 million a year ago, short of Wall Street estimates of $50.9 million in revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece appearing in Newsday likens familial DNA search to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.

Startup companies are taking on personalized medicine, CNET reports.